StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

NeoGenomics's price to sales ratio was 2.8× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 0.9× to 8.7×, with a median of 2.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.8×+0.7
2025Dec 31, 20252.1×−1.1
2024Dec 31, 20243.3×−0.3
2023Dec 29, 20233.6×+1.2
2022Dec 30, 20222.4×−6.3
2021Dec 31, 20218.7×−5.4
2020Dec 31, 202014.1×+6.0
2019Dec 31, 20198.0×+3.6
2018Dec 31, 20184.5×+1.5
2017Dec 29, 20173.0×−0.2
2016Dec 30, 20163.2×−1.7
2015Dec 31, 20154.9×+1.8
2014Dec 31, 20143.1×+0.3
2013Dec 31, 20132.8×+0.9
2012Dec 31, 20121.9×+0.4
2011Dec 30, 20111.5×–

More NeoGenomics figures

See a number that looks wrong?